Sativex UK – What It Is, How to Get Prescribed, Cost

Sativex UK: What It Is, How to how to get a medical cannabis prescription, and Cost

Sativex has become an increasingly discussed option for patients seeking cannabis-based medicine in the United Kingdom. This comprehensive guide explores everything you need to know about Sativex UK, including what it is, how to access it through prescription, and the associated costs.

What Is Sativex?

Sativex is a prescription medication containing cannabis extract derived from specific cannabis plant strains. Unlike recreational cannabis, Sativex is a standardised pharmaceutical product containing defined ratios of cannabinoids, primarily cannabidiol (CBD) and tetrahydrocannabinol (THC) in a 1:1 ratio.

The medication comes as an oromucosal spray, meaning it is sprayed inside the mouth where it absorbs through the mucous membranes. Each spray typically delivers 100 microlitres containing 2.7 mg of THC and 2.5 mg of CBD.

Sativex received its marketing authorisation in the European Union in 2014 and has been available in the UK through prescription since 2014. It is licensed specifically for treating spasticity associated with multiple sclerosis (MS), where muscle stiffness and spasms significantly impact quality of life.

Medical Uses and Clinical Evidence

Sativex UK is primarily prescribed for managing muscle spasticity in multiple sclerosis patients. Clinical trials demonstrate that approximately 70% of MS patients experienced improvements in spasticity symptoms when using Sativex compared to placebo.

The medication has also been investigated for other conditions, including chronic pain, cancer-related pain, and other neurological conditions. However, its licensed indication in the UK remains multiple sclerosis spasticity.

Research published in multiple peer-reviewed journals indicates that Sativex can reduce muscle tone, improve sleep quality, and enhance overall functional mobility in MS patients who have not responded adequately to other treatments.

How to how to get a medical cannabis prescription on the NHS

Accessing Sativex through the NHS requires navigating specific criteria and procedures. The Medicines and Healthcare products Regulatory Agency (MHRA) and NHS England have established guidelines for prescribing.

To be eligible for NHS Sativex prescription, you must meet these key requirements:

• Have a confirmed diagnosis of multiple sclerosis
• Experience moderate to severe spasticity unresponsive to other treatments
• Have already tried standard anti-spasticity medications without adequate symptom relief
• Be able to demonstrate a measurable response to the medication within 4 weeks of starting treatment

The prescription process typically begins with your neurologist or MS specialist reviewing your medical history and current treatment regimen. They will assess whether other standard treatments have been adequately trialled.

If deemed suitable, your specialist will initiate a trial period lasting 4 weeks. During this time, you must demonstrate a clinically significant improvement in spasticity symptoms—typically a reduction of at least 30% on the Ashworth scale, which measures muscle tone.

Should the trial prove successful, your neurologist can prescribe Sativex on a continuing basis through the NHS, though this remains relatively rare. As of recent data, fewer than 1,000 patients in the UK were receiving Sativex through NHS prescription.

Private Prescriptions for Sativex

Many UK patients unable to access Sativex through the NHS pursue private prescriptions. Private consultations with neurologists or specialist best UK best UK cannabis clinicsss can result in prescription if medical criteria are met.

Private prescriptions require consultation fees ranging from £150 to £500 per appointment, depending on the specialist and location. Some private clinics specialise in cannabis-based medicines and may be more familiar with Sativex prescribing.

Once a private prescription is obtained, you can purchase Sativex from licensed pharmacies across the UK that stock controlled medicines.

Sativex Cost in the UK

Understanding the financial aspect of Sativex UK is crucial for prospective users. Costs vary significantly depending on your prescription source.

NHS Prescription Costs: If prescribed through the NHS, standard prescription charges apply. As of 2024, this means most patients pay the standard prescription fee of £9.90 per item in England. Those eligible for free prescriptions pay nothing.

Private Prescription Costs: The Sativex medication itself costs approximately £500 to £800 per month when purchased privately. A typical 52-ml bottle containing approximately 90 sprays costs around £600 to £750.

Additional costs include initial consultation fees (£150-£500), follow-up appointments (£100-£300), and ongoing monitoring. Annual private treatment costs can easily exceed £6,000 to £10,000.

Comparison with Alternative Treatments: Other anti-spasticity medications like baclofen cost significantly less, ranging from £5 to £30 per month on prescription. However, Sativex may be more effective for patients not responding to conventional treatments.

Side Effects and Safety Considerations

Like all medications, Sativex carries potential side effects. Common side effects include dizziness, drowsiness, dry mouth, and fatigue. Approximately 20-30% of users experience mild adverse effects.

Serious side effects are rare but can include mood changes, dependency concerns, and impaired cognitive function. The THC content means Sativex can affect driving ability and mental health in some individuals.

Regular monitoring by your prescribing healthcare professional is essential to ensure continued safety and efficacy.

Future Outlook for Sativex UK

The landscape for cannabis-based medicines in the UK continues evolving. As more research emerges and patient awareness increases, Sativex accessibility may improve.

NHS availability remains limited, but advocacy groups and patient organisations continue lobbying for expanded access to cannabis-based medicines for appropriate conditions.

Conclusion

Sativex UK represents a significant option for multiple sclerosis patients with inadequately controlled spasticity. While NHS access remains challenging and costly, private prescriptions provide an alternative pathway. Understanding eligibility criteria, costs, and the prescription process enables informed decision-making regarding this medical cannabis product. Anyone considering Sativex should consult with their specialist to determine suitability within their individual circumstances.

“`

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Medical cannabis is a prescription-only medicine in the UK. Always consult a qualified healthcare professional. CannaZen is an information platform, not a medical provider.